Stefan Cordes, Angela Dispenzieri, Martha Q. Lacy, Suzanne R. Hayman, Francis K. Buadi, David Dingli, Shaji K. Kumar, William J. Hogan and Morie A. Gertz Ten-year survival after autologous stem cell transplantation for immunoglobulin light chain amyloidosis Cancer 118
Version of Record online: 15 JUN 2012 | DOI: 10.1002/cncr.27660
Autologous stem cell transplantation can offer durable benefit for patients with immunoglobulin light chain amyloidosis. The number of organs involved offers the greatest pretreatment prognostic value, whereas the lowest posttransplantation serum free light chain level offers the best posttreatment prognostic value.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field